TAG:
tripath imaging
Cytyc Acquires Digene To Expand Product Line
By Robert Michel | From the Volume IX No. 4 – March 11, 2002 Issue
CEO SUMMARY: Cytyc Corporation will pay more than one half billion dollars to purchase Digene, Inc., and its DNA Capture HPV test. For Cytyc, this may prove to be a strategic masterstroke. In the short term, it alters the competitive balance in the market for liquid preparation Pap testin…
Cytyc versus TriPath: Pap Wars Will Intensify
By Robert Michel | From the Volume IX No. 2 – January 28, 2002 Issue
CEO SUMMARY: Earlier this month, Cytyc Corporation announced that it had filed Pre-Market Applications (PMA) for two new product lines to complement its ThinPrep® liquid preparation kit. This is a sign that competition between the two major vendors is about to heat up. If so, it will hel…
Tripath Imaging Ready To Roil Pap Test Market
By Robert Michel | From the Volume VIII No. 17 – December 17, 2001 Issue
CEO SUMMARY: Single-handedly, Cytyc Corporation has built the market for thin-layer Pap smear testing. Executives at TriPath Imaging are now ready to challenge Cytyc’s dominance by offering what they believe is a different value proposition to labs: an automated liquid preparation syste…
Roche, Digene, Centrex, Labtest.com, Specialty Labs, Tripath Imaging
By Robert Michel | From the Volume VIII No. #15 – November 5, 2001 Issue
ROCHE DIAGNOSTICS POSITIONED TO SERVE PUBLIC HEALTH LABS HEIGHTENED CONCERNS over bioterrorist attacks have accelerated plans within the public health lab sector to acquire state-of-the art diagnostic technology in DNA typing and enzyme immunoassay. Roche Diagnostics has in…
“August 13, 2001 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VIII No. 11 – August 13, 2001 Issue
In recent years he’s become an influential “behind the scenes†guy within the lab industry. Now Heywood D. Cochrane, Jr. is joining the Board of Directors at AmeriPath, Inc., based in Riviera Beach, Florida. Most laboratorians know Cochrane from his tour as President and CEO of…
Atlas Development, Labtest.com, Bio-Reference Labs, Cytyc, TriPath Imaging
By Robert Michel | From the Volume VIII No. 2 – February 5, 2001 Issue
EARLY ADOPTERS OFFER WEB-ENABLED LAB TEST REPORTING TO DOCTORS THERE’S A GROWING NUMBER of clinical laboratories which now provide Web-enabled lab test reporting to their physician-clients. Dynacare, Inc. is in the first phase of a national roll-out of Web-enabled lab tes…
DNA Diagnostics Market, Kaiser Permanente, TriPath Imaging, LifeScan
By Robert Michel | From the Volume VIII No. 1 – January 15, 2001 Issue
DNA DIAGNOSTICS MARKET GROWTH TO BE DOMINATED BY PCR TECHNOLOGY FOR THE YEAR 2000, total DNA diagnostic technology sales were estimated to be $517 million. By 2005, this number should increase to $771 million, a growth rate of 8.4% per year. This is the conclusion of Laura Roth, author of â…
Accurate Costing of New Pap Technology Proves Interesting
By Robert Michel | From the Volume VII No. 13 – September 11, 2000 Issue
CEO SUMMARY: Various new technologies intended to supplant conventional Pap smear screening must deliver improved clinical performance in a cost-effective manner. Joseph Plandowski, our guest writer,concludes his three-part series on new Pap smear technologies by evaluating actual lab cos…
“September 11, 2000 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VII No. 13 – September 11, 2000 Issue
Here’s an interesting rumor. The September 11 is- sue of Business Week magazine says that Abbott Laboratories Inc. may acquire Beckman Coulter, Inc., based in Fullerton, California. Business Week quoted a financial analyst who believed the rumor w…
Market Hesitates to Embrace Automated Screening Products
By Robert Michel | From the Volume VII No. 12 – August 21, 2000 Issue
CEO SUMMARY: Technology to enhance and improve conventional Pap smear screening was introduced into the clinical marketplace almost five years ago. But the clinical laboratory industry has yet to embrace these various technologies in any meaningful way. Like the introduction of liquid pre…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized